If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday. ------- FTSE 100 - WINNERS ------- AstraZeneca, up 15%. US drugs giant Pfizer Inc has confirmed that it has now t
LONDON (Alliance News) - UK stocks indices are mixed Monday, with little in the economic calendar to provide direction and developments in Ukraine weighing on sentiment, but with a significant shot-in-the-arm provided by continued merger and and acquisition activity in the pharmaceutical sector.<
- AB Foods jumps, ARM and Sports Direct fall
- UK borrowing falls more than expected
- Chinese manufacturing still in contraction
- Eurozone business activity improves
techMARK 2,740.84 +0.09%
FTSE 100 6,670.05 -0.18%
FTSE 250 15,991.94 -0.56%
UK stocks pulled back from a three-week high on Wednes
- AB Foods jumps on Primark expansion plans
- Stocks rise, but upside limited
- BoE minutes, economic data ahead
- Chinese manufacturing PMI contracts again
techMARK 2,749.64 +0.41%
FTSE 100 6,688.65 +0.10%
FTSE 250 16,067.20 -0.09%
UK stocks edged higher on Wednesday morning with Primark owner As
LONDON (Alliance News) - UK equities closed mixed Tuesday, with large- and mid-cap stocks outperforming their smaller peers to end the day in positive territory for the third trading day in a row, as individual company news took centre stage.
Pharmaceuticals and biotechnology stocks were rising by an average of six per cent in London on Tuesday, helped by a wave of high-profile M&A deals across the global healthcare sector.
Leading the charge in the UK was AstraZeneca on reports that it could be at the centre of the largest deal in phar
Worldwide Healthcare Trust and Hikma Pharmaceuticals tracked their FTSE 100 peers higher after AstraZeneca gained strongly on the back of takeover speculation, Shire rose following broker comment, and GSK also jumped after announcing a massive three-part deal with Swiss pharmaceuticals peer Novartis
- FTSE 100 at highest since April 4th
- Astra jumps on Pfizer takeover speculation
- GSK announces massive three-part deal with Novartis
techMARK 2,741.04 +2.28%
FTSE 100 6,691.88 +1.01%
FTSE 250 16,103.19 +1.23%
Heightened M&A activity in the pharmaceutical sector gave UK markets a boost on Tues
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Tuesday. ------- FTSE 100 - WINNERS ------- AstraZeneca, up 7.1%. The pharmaceutical company has jumped after The Sunday
LONDON, April 22 (Reuters) - Shares in European drugmakers
received a shot in the arm on Tuesday amid a flurry of activity,
with Novartis striking a multi-billion dollar deal with
GlaxoSmithKline and reports U.S. giant Pfizer had approached
Britain's AstraZeneca over a deal. Pfizer and Astr
LONDON (Alliance News) - Pharmaceutical companies are leading UK stocks higher Tuesday, with the sector buoyed by merger and acquisition activity and speculation. With little in the way of economic data to provide focus, and in the absence of a further deterioration of the political situati